Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
Abstract BACKGROUND Preclinical studies suggest that creatine monohydrate (CrM) improves cognition and Alzheimer's disease (AD) biomarkers. However, there is currently no clinical evidence demonstrating the effects of CrM in patients with AD. METHODS In this single‐arm pilot trial, we investiga...
Saved in:
| Main Authors: | Aaron N. Smith, In‐Young Choi, Phil Lee, Debra K. Sullivan, Jeffrey M. Burns, Russell H. Swerdlow, Emma Kelly, Matthew K. Taylor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.70101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Creatine and post-viral fatigue syndrome: an update
by: Sergej M. Ostojic, et al.
Published: (2025-09-01) -
Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study
by: Victor Augusto Ramos Fernandes, et al.
Published: (2025-01-01) -
The Effect of Creatine on Muscle Mass Gain: A Literature Review
by: Artur Drzewiecki, et al.
Published: (2025-04-01) -
Additional Benefits of Creatine Monohydrate Supplementation on Muscle Strength, Muscle Mass Gain and Training Performance - A Systematic Review
by: Tadeusz Kuźnieców, et al.
Published: (2025-05-01) -
Creatine supplementation: bioavailability and effects on physical and cognitive performance
by: Monika Gajda-Bathelt, et al.
Published: (2025-07-01)